Biomemory banks on DNA to revolutionize data storage

Biomemory, a French startup, is developing data storage technology using DNA as support. This process offers unrivaled density, millennial durability and a reduced energy footprint, meeting the limits of current electronic solutions.

We welcome Erfan Arwani, CEO of BIO MEMORY in our show WHY CLOUD MATTERS? in partnership with OVHcloud. A show co-produced by CANALCHAT and FRENCHWEB.

DNA, an alternative to semiconductors

The principle of Biomemory is based on the transformation of digital data (0 and 1) into DNA sequences (ATGC), encapsulated in a compact card called DNA Card. Unlike hard drives and flash memories, whose lifespan does not exceed five years, DNA can store data for several thousand years. Its exceptional density significantly reduces the space required: all the world’s data could fit, theoretically, in a glass of water.

Faced with the exponential growth of digital data (+100% every three years) and the physical limits of semiconductors, DNA offers a sustainable solution for long-term storage needs. “We are harnessing a polymer that nature has perfected over millions of years,” explains Erfan Arwani, co-founder and CEO of Biomemory.

Vast and strategic applications

The technology is aimed at sectors where storage requirements are critical: health, artificial intelligence, manufacturing and regulation. For example, notaries, subject to data retention obligations over several decades, could benefit from this innovation. In the short term, Biomemory is targeting data centers, where demand for resilient and high-capacity solutions is growing strongly.

Standardisation et collaboration internationale

Biomemory is a member of the DNA Data Storage Alliancealongside Microsoft, Western Digital, Twist Bioscience and Illumina. This international collaboration aims to establish standards to encourage the adoption of DNA as a storage medium and raise awareness among industrial players.

An ambitious vision for 2030

The startup plans to launch a service called Writing as a Service from 2025, allowing the storage of DNA data for specific purposes. The final objective, by 2030, is to market solutions that can be integrated directly into data centers, offering a user experience comparable to that of current technologies.

Structuring financial support

To support this ambition, Biomemory recently raised 17 million euros from Crédit Mutuel Innovation, BPI France (Deep Tech 2030) and Blast. These funds will make it possible to finalize the industrialization of the technology and accelerate its introduction to the market.

You can find us on SPOTIFY, DEEZER and in a few days on APPLE PODCAST. See you every first Monday of the month for WHY CLOUD MATTERS, do not hesitate to send us your comments and suggestions! [email protected]